CAH vs EMAT · P/E 35, rev $254.25B vs rev $3.5M
Cardinal Health Inc (CAH) versus Evolution Metals & Technologies Corp. Common Stock (EMAT) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Evolution Metals & Technologies Corp. Common Stock (EMAT) is a other industrial metals & mining company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported EMAT revenue for 2026-06-30 was $3.5M. Net income was -$452.2M. Revenue was up 87.1% from 2026-03-31 to 2026-06-30. EMAT currently screens at market cap $4.30B.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. EMAT currently screens at market cap $4.30B.
Not investment advice. Open the CAH and EMAT stock pages for the full models.
Not investment advice.